Comprehensive Overview of Indocyanine Green (ICG) Angiography

Indocyanine Green (ICG) angiography represents a pinnacle of real-time intraoperative and diagnostic imaging. By utilizing a near-infrared (NIR) fluorescent dye, surgeons and radiologists can visualize tissue perfusion, vascular patency, and lymphatic drainage with unprecedented precision. Unlike traditional contrast agents that require ionizing radiation, ICG angiography offers a dynamic, non-radioactive method to assess the physiological health of tissues in real-time.

In the orthopedic and surgical landscape, this technology has revolutionized the management of complex wounds, flap reconstructions, and vascular assessments. It provides the clinician with an "augmented reality" view of blood flow, allowing for critical decision-making during procedures that might otherwise rely on subjective clinical judgment.

Technical Specifications and Mechanism of Action

The utility of ICG angiography lies in the unique photophysical properties of the Indocyanine Green molecule.

The Physics of Fluorescence

ICG is a water-soluble tricarbocyanine dye. When injected intravenously, it binds rapidly to plasma proteins (primarily albumin), which keeps the dye intravascular, preventing immediate extravasation into the interstitial space.

• Excitation/Emission: ICG is excited by near-infrared light (typically 760–780 nm) and emits fluorescence at a peak wavelength of approximately 830 nm.
• Tissue Penetration: NIR light has superior tissue penetration compared to visible light, allowing for the visualization of blood flow several millimeters beneath the tissue surface.
• Real-time Dynamic Imaging: Because the dye remains within the vasculature during the initial transit phase, it provides a high-fidelity "movie" of blood flow rather than a static snapshot.

Comparison Table: ICG vs. Conventional Imaging

Clinical Indications and Surgical Usage

The application of ICG angiography spans multiple disciplines, but its impact in orthopedics and plastic surgery is profound.

1. Orthopedic and Trauma Surgery

• Assessment of Fracture Vascularity: Evaluating the blood supply to femoral heads or talar fractures where the risk of avascular necrosis (AVN) is high.
• Soft Tissue Coverage: Determining the viability of soft tissue flaps before definitive closure in open fractures.
• Hardware Integration: Assessing if surrounding soft tissues have adequate perfusion to support bone healing and hardware placement.

2. Plastic and Reconstructive Surgery

• Free Flap Monitoring: Ensuring the arterial inflow and venous outflow of a microvascular free flap are patent immediately post-anastomosis.
• Mastectomy Skin Flap Viability: Reducing the risk of skin necrosis by identifying poorly perfused areas that require debridement before closure.

3. Vascular and General Surgery

• Lymphatic Mapping: Identifying sentinel lymph nodes for oncology staging.
• Bowel Perfusion: Assessing anastomotic integrity during colorectal surgery to prevent leaks.

Patient Preparation and Procedural Workflow

Preparation for ICG angiography is relatively straightforward but requires strict adherence to safety protocols.

Pre-Procedure Checklist

1. Allergy Screening: Although rare, patients must be screened for iodine hypersensitivity.
2. Hydration: Ensuring adequate intravascular volume to facilitate optimal dye transit.
3. Baseline Assessment: Documenting pre-dye clinical appearance of the surgical site.

The Procedure Steps

1. Intravenous Access: A peripheral line is established, usually in the upper extremity.
2. Dye Administration: ICG is reconstituted in sterile water and administered as a bolus injection (typically 2.5mg to 5mg, depending on the protocol).
3. NIR Illumination: The surgeon activates the NIR camera system.
4. Observation: The camera records the "wash-in" (arterial phase) and "wash-out" (venous phase) of the dye.
5. Data Analysis: The surgeon observes the fluorescence intensity. Areas with delayed or absent fluorescence indicate vascular compromise.

Risks, Side Effects, and Contraindications

While ICG has an excellent safety profile, clinicians must remain vigilant.

Potential Risks

• Anaphylaxis: ICG contains sodium iodide. While the iodine is bound within the molecule, patients with severe iodine allergies should be treated with extreme caution or excluded.
• Extravasation: If the dye leaks into the surrounding tissue, it may cause local irritation, though permanent damage is rare.
• Interference: High ambient light in the operating room can sometimes cause artifacts, requiring careful calibration of the NIR system.

Contraindications

• Iodine Allergy: Absolute contraindication in patients with a history of anaphylaxis to iodine.
• Pregnancy: Data on safety during pregnancy is limited; it is generally avoided unless the clinical necessity outweighs the risk.
• Thyroid Pathologies: Caution is advised in patients with hyperthyroidism or thyroid adenomas, as ICG may interfere with thyroid metabolism.

Interpretation of Results: Normal vs. Abnormal

The interpretation of ICG imaging is based on the Time-to-Peak (TTP) and Fluorescence Intensity (FI).

Normal Findings

• Rapid Inflow: Immediate, symmetrical fluorescence appearing in the target tissue within 10–30 seconds.
• Homogeneity: Uniform brightness across the tissue bed, indicating healthy microvascular circulation.
• Clear Wash-out: A gradual transition as the dye is cleared by the liver (half-life of 3–4 minutes).

Abnormal Findings

• Delayed Inflow: A significant lag in fluorescence suggests arterial insufficiency or proximal blockage.
• Heterogeneous/Patchy Pattern: Suggests microvascular thrombosis or inadequate collateral circulation.
• "Dark" Zones: Total absence of fluorescence indicates frank ischemia, which in a surgical context, often necessitates immediate debridement or surgical revision.

Frequently Asked Questions (FAQ)

1. Is ICG angiography considered a radioactive procedure?

No. ICG is a fluorescent dye, not a radioactive isotope. It does not emit ionizing radiation, making it safe for repeated use during the same procedure.

2. How long does ICG stay in the patient’s system?

ICG is cleared rapidly by the liver and excreted into the bile. It has a plasma half-life of approximately 3 to 4 minutes, and it is usually cleared from the body within 24 hours.

3. Can ICG be used in patients with renal failure?

Yes. Unlike CT contrast (iodinated contrast media), ICG is not nephrotoxic and is primarily processed by the liver, making it a safer option for patients with impaired kidney function.

4. What is the most common side effect of ICG?

Side effects are rare, occurring in less than 0.05% of cases. When they do occur, they are typically mild, such as nausea, pruritus (itching), or transient hypotension.

5. Does the fluorescence fade quickly?

Yes, the fluorescence is dynamic. The initial bolus provides a "peak" of brightness that lasts for a few minutes, which is sufficient time for the surgeon to evaluate the vascularity of the target area.

6. Can ICG be used to look at deep organs?

The depth of visualization depends on the NIR system, but generally, ICG can penetrate 5–10 mm into the tissue. It is excellent for surface-level perfusion and superficial organ assessments.

7. Does ICG interact with other medications?

There are few known interactions. However, drugs that compete for hepatic uptake (such as phenytoin or heparin) may theoretically alter the clearance rate.

8. Is special training required to interpret ICG images?

While the images are intuitive (bright = good blood flow), surgeons require training to distinguish between physiological variation and pathological ischemia.

9. Why is it called "Indocyanine Green"?

The name is derived from its chemical structure and its color in solution, which is a deep, dark green.

10. Can ICG be used for pediatric patients?

Yes, ICG has been used in pediatric surgery for lymphatic mapping and vascular assessment, though dosing must be carefully adjusted based on the child's weight.

Conclusion

Indocyanine Green (ICG) Angiography has fundamentally shifted the paradigm of surgical precision. By providing a real-time, non-invasive, and highly accurate map of tissue perfusion, it empowers orthopedic and reconstructive surgeons to make data-driven decisions that improve patient outcomes. As imaging technology continues to evolve, the integration of ICG into standard surgical workflows will likely become the gold standard for assessing tissue viability, ultimately reducing complication rates in complex surgical interventions.